Evidence map›Paper›PMID 41019533›Full record

ArticleFrontiers in microbiology2025

Multi-omics integration reveals gut microbiota dysbiosis and metabolic alterations of cerebrospinal fluid in children with epilepsy.

Feng Li, Dongdong You, Yun Li, Xiaoyu Wang, Zhongdong Lin, Xulai Shi, Zhongshan Li, Jinyu Wu, Zhenwei Liu

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. IntestinalFrontiers in neuroscience · 2026
    Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Feng LiDepartment of Pediatric Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Dongdong YouDepartment of Neonatology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Yun LiKey Laboratory of Laboratory Medicine, Ministry of Education, Institute of Genomic Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Xiaoyu WangDepartment of Pediatric Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Zhongdong LinDepartment of Pediatric Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Xulai ShiDepartment of Pediatric Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Zhongshan LiKey Laboratory of Laboratory Medicine, Ministry of Education, Institute of Genomic Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Jinyu WuKey Laboratory of Laboratory Medicine, Ministry of Education, Institute of Genomic Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Zhenwei LiuKey Laboratory of Laboratory Medicine, Ministry of Education, Institute of Genomic Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Epilepsy is a complex neurological disorder with an unclear pathogenesis. Emerging evidence suggests that gut microbiota dysbiosis and cerebrospinal fluid (CSF) metabolic alterations play a critical role in epilepsy progression through the gut-brain axis. This study aimed to characterize microbial and metabolic disturbances in pediatric epilepsy and identify potential diagnostic biomarkers through integrative multi-omics analysis of matched fecal and CSF samples. Methods: In this study, we conducted 16S rRNA gene sequencing on fecal samples from a total of 50 participants including 17 common epilepsy (CEP) patients, 23 refractory epilepsy (REP) patients, and 10 non-epilepsy (NEP) patients, along with untargeted metabolomic analysis on 24 paired CSF samples from REP and NEP groups. Multi-omics integration and a random forest model were applied to assess diagnostic performance, identifying microbial and metabolite signatures associated with epilepsy. Results: Children with epilepsy (REP and CEP) exhibited distinct gut microbiota dysbiosis. Specifically, multivariable association modeling using MaAsLin 3 identified 13 discriminatory microbial taxa, with Conclusion: These findings reveal concurrent gut microbiota dysbiosis and CSF metabolic disturbances in epilepsy, underscoring their interrelated roles in epileptogenesis and reinforcing our understanding of microbiome-metabolome crosstalk. The integrated multi-omics model demonstrated superior diagnostic performance, emphasizing its potential for precision biomarker discovery and clinical application in epilepsy stratification and intervention.

Indexed as

cerebrospinal fluidepilepsygut-brain axisgut microbiotametabolomics

Identifiers

PMID41019533
PMCPMC12461256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.